Automatically clustered newsroom coverage around one of the most active themes in the intellectual property ecosystem.
Autonomix Medical has been granted Canadian Patent No. 3,158,197, titled "Endoscopic Sympathectomy Systems and Methods," marking a significant expansion of its intellectual property assets. The patent covers advanced technologies for real-time nerve sensing, mapping, and feedback-guided neuromodulation, designed to im…
Genprex, Inc. announced that the Canadian Intellectual Property Office has issued a Notice of Allowance for a patent protecting the use of its REQORSA gene therapy in combination with PD-1 or PD-L1 antibodies to treat non-small cell and small cell lung cancers. This patent complements existing approvals in multiple co…
Kolon Life Science has obtained a Canadian patent allowance for its innovative large-scale production method of KLS-3021, an oncolytic virus candidate targeting solid tumors. This patent enhances the company’s intellectual property assets across key markets including South Korea, the US, Europe, and China, supporting…
Subscribe to receive daily and weekly newsroom coverage aligned to this trend cluster and adjacent IP developments.